Wawruszak, A.; Luszczki, J.J.; Kalafut, J.; Okla, K.; Halasa, M.; Rivero-Muller, A.; Stepulak, A.
Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis. Int. J. Mol. Sci. 2019, 20, 3663.
https://doi.org/10.3390/ijms20153663
AMA Style
Wawruszak A, Luszczki JJ, Kalafut J, Okla K, Halasa M, Rivero-Muller A, Stepulak A.
Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis. International Journal of Molecular Sciences. 2019; 20(15):3663.
https://doi.org/10.3390/ijms20153663
Chicago/Turabian Style
Wawruszak, Anna, Jarogniew J. Luszczki, Joanna Kalafut, Karolina Okla, Marta Halasa, Adolfo Rivero-Muller, and Andrzej Stepulak.
2019. "Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis" International Journal of Molecular Sciences 20, no. 15: 3663.
https://doi.org/10.3390/ijms20153663
APA Style
Wawruszak, A., Luszczki, J. J., Kalafut, J., Okla, K., Halasa, M., Rivero-Muller, A., & Stepulak, A.
(2019). Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis. International Journal of Molecular Sciences, 20(15), 3663.
https://doi.org/10.3390/ijms20153663
